Lifecore Biomedical, Inc. \de\ LFCR

What this company does

Lifecore Biomedical, Inc., located in Chaska, Minnesota, is a contract development and manufacturing organization that provides development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug and medical device products in syringes, vials and cartridges, across a wide variety of modalities. It also manufactures hyaluronic acid in bulk form as well as in formulated and filled syringes and vials for customers' injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. It operates three facilities with a combined 250,000 square feet in Chaska, Minnesota, located within two miles of one another and regulated under one FDA establishment identifier number. As of May 25, 2025, the company had 406 full-time employees, all located in the United States, none of whom were represented by labor unions or collective bargaining agreements. The company's chief operating decision maker manages its CDMO and HA manufacturing operations on the basis of a single integrated segment. The company was incorporated under the laws of the State of Delaware under its prior corporate name in 2007. Lifecore's predecessor business commenced in the mid-1960s with a primary focus on microbial diagnostic devices, and it developed its HA capabilities in the early 1980s. In 2022, it changed its corporate name from Landec Corporation to Lifecore Biomedical, Inc.

Written from the business description in Lifecore Biomedical, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 7 August 2025. Every sentence was checked against that document before publication.